We are live on ! Find out more
TECH icon

Bio-Techne

355 hedge funds and large institutions have $7.06B invested in Bio-Techne in 2019 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 127 increasing their positions, 110 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

133% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 24

38% more capital invested

Capital invested by funds: $5.12B → $7.06B (+$1.94B)

15% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 110

9% more funds holding

Funds holding: 327355 (+28)

0.05% less ownership

Funds ownership: 376.56%376.51% (-0.05%)

34% less call options, than puts

Call options by funds: $2.94M | Put options by funds: $4.47M

Holders
355
Holders Change
+28
Holders Change %
+8.56%
% of All Funds
7.68%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
56
Increased
127
Reduced
110
Closed
24
Calls
$2.94M
Puts
$4.47M
Net Calls
-$1.53M
Net Calls Change
-$2.27M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$760M -$5.43M -120,600 -0.8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$694M +$8.86M +196,860 +1%
BCM
3
Brown Capital Management
Maryland
$332M -$5.71M -126,900 -2%
BAMCO Inc
4
BAMCO Inc
New York
$311M +$6.2M +137,824 +2%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$306M +$46.2M +1,027,296 +20%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$279M -$6.41M -142,500 -2%
Neuberger Berman Group
7
Neuberger Berman Group
New York
$276M -$6.31M -140,164 -2%
ACM
8
Atlanta Capital Management
Georgia
$266M -$1.56M -34,608 -0.6%
MPI
9
Mairs & Power Inc
Minnesota
$229M -$6.59M -146,448 -3%
State Street
10
State Street
Massachusetts
$182M +$2.47M +54,904 +2%
JSP
11
Jackson Square Partners
California
$175M +$6M +133,428 +4%
Massachusetts Financial Services
12
Massachusetts Financial Services
Massachusetts
$170M +$9.36M +207,968 +6%
FAM
13
Fred Alger Management
New York
$151M -$9.22M -204,944 -6%
CIP
14
Champlain Investment Partners
Vermont
$143M +$2.16M +47,960 +2%
First Trust Advisors
15
First Trust Advisors
Illinois
$133M -$13.7M -304,928 -10%
DDC
16
DF Dent & Co
Maryland
$119M +$15.4M +342,684 +17%
Ameriprise
17
Ameriprise
Minnesota
$110M +$12M +265,812 +14%
Invesco
18
Invesco
Georgia
$107M -$2.47M -54,888 -2%
Renaissance Technologies
19
Renaissance Technologies
New York
$97.4M -$23.6M -523,600 -21%
Norges Bank
20
Norges Bank
Norway
$96.3M -$1.03M -22,928 -1%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$91.8M -$2.44M -54,112 -3%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$84.6M +$1.75M +38,800 +2%
RP
23
Riverbridge Partners
Minnesota
$84.3M -$9.23M -205,040 -11%
1WCM
24
12 West Capital Management
New York
$70.7M +$6.3M +140,000 +11%
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$69.9M +$162K +3,600 +0.3%

TECH Hedge Fund Activity: Q1 2019 in Review

355 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2019, worth a combined $7.06B — up 38% from $5.12B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new TECH positions and 24 closed out — a net gain of 32 holders — while 127 added to existing stakes and 110 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $46.2M. The largest seller was AQR Capital Management, cutting an estimated $30.7M.

  • 355 institutional investors held Bio-Techne (TECH) as of Q1 2019, up from 327 in Q4 2018.
  • Funds reported $7.06B of Bio-Techne stock for Q1 2019, up 38% quarter-over-quarter.
  • 56 funds opened new Bio-Techne positions in Q1 2019 and 24 closed out, a net change of +32 holders.
  • The largest Bio-Techne buyer in Q1 2019 was Wellington Management Group, an estimated $46.2M added.
  • The largest Bio-Techne seller in Q1 2019 was AQR Capital Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q1 2019.